Affiliation:
1. Department of Public Health, Sahmyook University, Seoul 01795, Republic of Korea
Abstract
This study assessed pre-exposure prophylaxis (PrEP) awareness, knowledge, and attitudes in a sample of 1389 men who have sex with men (MSM). Using a self-report survey, we measured PrEP knowledge mean scores, attitudes toward PrEP, and awareness rates to identify the key influences on PrEP uptake. PrEP awareness among participants was 66.3%, with 33.7% having never heard of PrEP. Approximately 4.5% had previous experience with PrEP but were not current users, while only 2.7% reported that they were currently taking it. Logistic regression analysis revealed that the significant predictors of PrEP awareness were educational attainment, marital status, prior HIV testing knowledge, and attitudes toward PrEP. Several demographic factors were not significant predictors of intention to use PrEP; however, using the internet to meet partners, number of partners, HIV testing, positive attitudes, and reduced perceived barriers played a critical role in shaping PrEP use intentions. These findings highlight the critical role of targeted educational strategies and tailored public health messaging in enhancing the awareness and intention to use PrEP among MSM.
Reference22 articles.
1. Sohn, A. (2023). Trends in human immunodeficiency virus-related knowledge and stigma among men who have sex with men in the republic of Korea from 2012 to 2022. Healthcare, 11.
2. Kim, S.B., Yoon, M., Ku, N.S., Kim, M.H., Song, J.E., Ahn, J.Y., Jeong, S.J., Kim, C., Kwon, H.-D., and Lee, J. (2014). Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea. PLoS ONE, 9.
3. HIV/AIDS Notifications in Korea, 2022;Kim;Public Health Wkly. Rep.,2023
4. Knowledge, attitudes, and sexual behaviors in HIV/AIDS and predictors affecting condom use among men who have sex with men in South Korea;Sohn;Osong Public Health Res. Perspect.,2012
5. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058;Richter;Eurosurveillance,2019